Neochlorogenic Acid Inhibits Lipopolysaccharide-Induced Activation and Pro-inflammatory Responses in BV2 Microglial Cells

Neurochemical Research

Volumn 40, Issue 9, 2015, Pages 1792-1798

  Kim, Mina ^a   Choi, Sang Yoon ^a,b   Lee, Pyeongjae ^c   Hur, Jinyoung ^a,b  

^a Korea Food Research Institute   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Semyung University   (South Korea)

Author keywords

BV2; Lipopolysaccharide; Microglia activation; Neochlorogenic acid; Neuroinflammation

Indexed keywords

CYCLOOXYGENASE 2; DEXAMETHASONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEOCHLOROGENIC ACID; NITRIC OXIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; 5'-O-CAFFEOYLQUINIC ACID; CHLOROGENIC ACID; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; QUINIC ACID;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN; CELL ACTIVATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DEGRADATION; DRUG EFFICACY; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; INFLAMMATION; METABOLISM; PATHOLOGY;

ANIMALS; CELL LINE; CHLOROGENIC ACID; CYCLOOXYGENASE 2 INHIBITORS; CYTOKINES; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; QUINIC ACID;

EID: 84940725126     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1659-1     Document Type: Article

References (32)

1. Aguzzi A, Barres BA, Bennett ML (2013) Microglia: Scapegoat, saboteur, or something else? Science 339:156–161
2. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanism. Nat Rev Neurosci 8:57–69
3. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314–1318
4. Ock J, Han HS, Hong SH, Lee SY, Han YM, Kwon BM, Suk K (2010) Obovatal attenuates microglia-mediated neuroinflammation by modulating redox regulation. Br J Pharmacol 159:1646–1662
5. Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6:193–201
6. Rivest S (2003) Molecular insights on the cerebral innate immune system. Brain Behav Immun 17:13–19
7. Das S, Basu A (2008) Inflammation: a new candidate in modulating adult neurogenesis. J Neurosci Res 86:1199–1208
8. Lue LF, Kuo YM, Beach T, Walker DG (2010) Microglia activation and anti-inflammatory regulation in Alzheimer’s disease. Mol Neurobiol 41:115–128
9. Long-Smith CM, Sullivan AM, Nolan YM (2009) The influence of microglia on the pathogenesis of Parkinson’s disease. Prog Neurobiol 89:227–287
10. Glass CK, Saijo K, Winner B, Matchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918–934
11. Infante R, Contador L, Rubil P, Aros D, Pena-Neira Á (2011) Postharvest sensory and phenolic characterization of ‘Elegant Lady’ and ‘Carson’ peaches. Chil J Agric Res 71:445–451
12. Chen Y, Li SG, Lin XH, Luo HB, Li GG, Yao H (2008) On-line screening and identification of radical scavenging compounds extracted from Flos Lonicerae by LC-DAD-TOF-MS. Chromatographia 68:327–333
13. Hung XM, Na M, Thuong PT, Su NA, Sok D, Song KS, Seong YH, Bae K (2006) Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper Wall. J Ethnopharmacol 108:188–192
14. Mishima S, Yoshida C, Akino S, Sakamoto T (2005) Antihypertensive effects of Brazillian propolis: identification of caffeoylquinic acids as constituents involved in the hypotension in spontaneously hypertensive rats. Biol Pharm Bull 28:1909–1914
15. Koo HJ, Lim KH, Jung HJ, Park EH (2006) Anti-inflammatory evaluation of gardenia extract, geniposide and genipin. J Ethnopharmacol 103:496–500
16. Korhnen R, Lahti A, Hämäläinen M, Kankaanranta H, Moilanen E (2002) Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol Pharmacol 62:698–704
17. Liu B, Hong J-s (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol 304:1–7
18. Minghetti L, Levi G (1998) Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 54:99–125
19. Rivest S (2011) The promise of anti-inflammatory therapies for CNS injuries and diseases. Expert Rev Neurother 11:783–786
20. Murphy S (2000) Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 29:1–13
21. Brown GC, Borutaite V (2002) Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic Biol Med 33:1440–1450
22. Minghetti L (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63:901–910
23. Merson TD, Binder MD, Kilpatrik TJ (2010) Role of cytokines as mediators and regulators of microglia activity in inflammatory demylination of the CNS. Neuromol Med 12:99–132
24. Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P (2006) Neuroinflammation and regeneration in the early stages of Alzheimer’s disease pathology. Int J Dev Neurosci 24:157–165
25. Inoue K (2006) The function of microglia through purinergic receptors: neuropathic pain and cytokines release. Pharmacol Ther 109:210–226
26. He FQ, Qiu BY, Zhang XH, Li TK, Xie Q, Cui DJ et al (2011) Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer’s disease induced by amyloid-β (1–42). Brain Res 1384:89–96
27. Yeo SJ, Yoo JG, Yi AK (2003) Myeloid differentiation factor 88-dependent post-necrosis factor-alpha receptor- associated factor 6, a diverging point in the Toll-like receptor 9-signaling. J Biol Chem 278:40590–40600
28. Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Res Immunol 27:693–733
29. Kaminska B, Gozdz A, Zawadzka M, Ellert-Miklaszewska A, Lipko M (2009) MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat Rec 292:1902–1913
30. Krementsov DN, Thornton TM, Teuscher C, Rincon M (2013) The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models. Mol Cell Biol 33:3728–3734
31. Branger J, van den Blink B, Weijer S, Madwed J, Bos CL et al (2006) Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J Immunol 168:4070–4077
32. Ashwell JD (2006) The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev Immunol 6:532–540